Further to DrugAlert volume 917, HPS Pharmacies wishes to advise that some morphine oral solutions available under Section 19A of the Therapeutic Goods Act 1989 are now subsidised on the Pharmaceutical Benefits Scheme (PBS).

Section 19A products now subsidised on the PBS include:

  • Morphine sulfate 10mg/5mL oral solution (Martindale Pharma)
    • A-flagged to Ordine® 2 in the PBS schedule for general listings; no a-flagging for palliative care listing
    • Product contains ethanol (0.4mL/5mL) and sucrose (2.25g/5mL).
  • Morphine sulfate 10mg/5ml oral solution (Hikma)
    • A-flagged to Ordine® 2 in the PBS schedule for general listings; no a-flagging for palliative care listing
    • Sugar and alcohol free
  • Morphini HCl Streuli (morphine hydrochloride) 10mg/mL oral drops (Switzerland)
    • A-flagged to Ordine® 10 in the PBS schedule for general and palliative care listings
    • Product is not labelled in English; additional care required when storing and dispensing this medicine. Health professionals should refer to the Australian product information for dosing information.
    • Product contains alcohol (1.2% v/v).

Further information on PBS subsidies for S19A products is available on the PBS website.

Arrotex has taken over the sponsorship of Ordine® products and anticipates that supplies of all strengths of Ordine® Oral Solution will resume by late August 2024.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

 

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates